Add BrightSurf on Google Email

Tumor-secreted protein may hold the key to better treatments for deadly brain tumor, study finds

A study suggests targeting endocan, a protein produced by endothelial cells in blood vessels, could slow tumor growth and make glioblastoma more vulnerable to existing treatments. The discovery may lead to new strategies to combat glioblastoma, which has an average lifespan of just 12-15 months.

New approaches against metastatic breast cancer: mini-tumors from circulating cancer cells

Scientists cultivate stable tumor organoids directly from blood samples of breast cancer patients, revealing a molecular signaling pathway that ensures cancer cell survival and resistance to therapy. The team develops an approach to specifically eliminate these tumor cells in lab experiments.

Researchers from Korea University explore how ascorbic acid and FGF4 revolutionize regenerative medicine

Researchers from Korea University have developed a groundbreaking technique to transform fibroblasts into mature cardiomyocytes, holding promise for regenerative medicine in treating cardiovascular disease. The method combines fibroblast growth factor 4 (FGF4) with vitamin C to accelerate cell maturation and enhance function.

SourceKorea University College of Medicine·JournalExperimental & Molecular Medicine·TypeExperimental study·DateDec 24, 2024

New insights into genes' role in craniofacial development and genetic disorder

A team of experts has discovered that the ARID1A gene regulates a critical genetic program for cell migration, with ZIC2 identified as a crucial regulator in this process. This study expands our understanding of craniofacial development and provides valuable insights into the genetic causes of congenital diseases.

SourceUniversidad Miguel Hernandez de Elche·JournalAmerican Journal of Human Genetics·TypeExperimental study·DateDec 13, 2024

Gottfried Wilhelm Leibniz Prizes 2025

The 2025 Gottfried Wilhelm Leibniz Prizes were awarded to four female and six male researchers, with two working in the humanities and social sciences, four in life sciences, three in natural sciences, and one in engineering sciences. The winners received €2.5 million each to fund their research for up to seven years.

USC Stem Cell study breaks the silence on how fish and lizards regenerate hearing

A USC Stem Cell study has identified key gene regulators that enable some deafened animals, including fish and lizards, to naturally regenerate their hearing. The researchers found a class of DNA control elements known as 'enhancers' that amplify the production of a protein called ATOH1, which induces sensory cells in the inner ear.

SourceKeck School of Medicine of USC·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateDec 9, 2024

New study details why aging cells struggle to heal

A new study published in Nature Aging details the changes in muscle regeneration over time, finding that immune cells exhibit differences in abundance and reaction time between age groups. The research also identifies altered stem cell states, leading to discoordination in the process of muscle repair in older mice.

SourceCornell University·JournalNature Aging·DateDec 2, 2024

Revolutionary bioengineering research may transform type 1 diabetes care, pave way for tackling cancer and autoimmune disease

Researchers at Medical University of South Carolina and University of Florida developed a novel approach to treat type 1 diabetes using tagged beta cell transplant with localized immune protection. The study, published in Cell Reports, shows promise for creating an off-the-shelf solution for T1D treatment.

SourceMedical University of South Carolina·JournalCell Reports·DateNov 25, 2024

Fighting aging by staying compact

Researchers at Weill Cornell Medicine discovered that keeping the nucleolus small can delay aging in yeast cells. This finding could lead to new longevity treatments and may also reveal a mortality timer that determines how long a cell has left before it dies.

SourceWeill Cornell Medicine·JournalNature Aging·DateNov 25, 2024

The origin of stem cells

Researchers identified critical proteins involved in animal stem cell regulation, including SOX and POU transcription factors, which existed in single-celled organisms over 700 million years ago. These ancient proteins retained functional properties that enabled them to induce stem cell reprogramming in mouse cells.

SourceMax-Planck-Gesellschaft·JournalNature Communications·DateNov 21, 2024

By exerting “crowd control” over mouse cells, scientists make progress towards engineering tissues

Researchers create system to manipulate cell behavior using 'crowd control' technique, enabling predictable patterns and structures. Cell density plays key role in guiding cellular development, offering potential for medical applications such as tissue engineering and organ regeneration.

SourceKeck School of Medicine of USC·JournalNature Communications·TypeExperimental study·DateNov 19, 2024

How marine worms regenerate lost body parts

Researchers from the University of Vienna have discovered that marine worms regenerate lost body parts by dedifferentiation, where cells return to a stem cell-like state. This process allows them to form new segments quickly, with specific gene expression and transcription factors involved.

SourceUniversity of Vienna·JournalNature Communications·DateNov 18, 2024

Human stem cell-derived heart cells are safe in monkeys, could treat congenital heart disease

Researchers have successfully transplanted human stem cell-derived heart cells into monkeys with a rare heart condition, offering a potential treatment for congenital heart defects. The study demonstrated the safety and integration of these cells into the host myocardium, paving the way for future clinical applications.

SourceUniversity of Wisconsin-Madison·JournalCell Transplantation·TypeExperimental study·DateNov 13, 2024

City of Hope Research Spotlight, October 2024

Researchers at City of Hope have made significant strides in the biology behind our sense of smell, finding new ways to treat esophageal cancer, and improving management of type 2 diabetes. The team's discoveries include a better understanding of odorant receptors and the potential for novel immunotherapies for cancer treatment.

Boston Medical Center and Boston University researchers one step closer to developing cell-based therapy for hypothyroidism

Boston Medical Center and Boston University researchers have made a breakthrough in developing cell-based therapy for hypothyroidism. They derived transplantable thyroid follicular epithelial cells from human induced pluripotent stem cells, which can be transplanted into thyroid-deficient animal models.

SourceBoston Medical Center·JournalStem Cell Reports·DateNov 7, 2024

Space: A new frontier for exploring stem cell therapy

Researchers found that microgravity can strengthen the regenerative potential of cells, leading to improved growth and function. This discovery has potential clinical applications for treating age-related conditions such as stroke, dementia, neurodegenerative diseases, and cancer.

SourceMayo Clinic·JournalNature·DateNov 4, 2024

'Black box' of stem cell transplants opened in world-first blood study

Researchers tracked the long-term dynamics of transplanted stem cells in patients' bodies up to three decades post-transplant. They found that younger donors produce more vital stem cells, while older donors experience reduced immunity and higher relapse risk. The study provides new insights into donor selection and transplant success.

SourceWellcome Trust Sanger Institute·JournalNature·TypeObservational study·DateOct 30, 2024

Using stem cell-derived artificial organelles to improve neural oxidative phosphorylation imbalances

A new framework called Engine Repair Theory uses self-assembling organelles derived from neural stem cells to restore mitochondrial energy homeostasis and mitigate oxidative stress. The study demonstrates an increase in ATP production and reduced cell damage, offering a promising approach for treating neurodegenerative conditions.

SourceDalian Stem Cell and Precision Medicine Innovation Research Institute·JournalNature Communications·TypeExperimental study·DateOct 27, 2024